SPI Bio began its operations in January 2014 after the successful validation of BioAlert technology in real-life conditions. The benefits of the technology were quickly recognized by financial and industrial partners, which provided the company with necessary resources for early product commercialisation. Today, SPI Bio represents a multidisciplinary team combining experts in biotechnology and optical detection systems as well as specialists in sales and marketing in order to make this innovative technology a commercial success.
SPI Bio began its operations in January 2014 after the successful validation of BioAlert technology in real-life conditions. The benefits of the technology were quickly recognized by financial and industrial partners, which provided the company with necessary resources for early product commercialisation. Today, SPI Bio represents a multidisciplinary team combining experts in biotechnology and optical detection systems as well as specialists in sales and marketing in order to make this innovative technology a commercial success.